Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Leo needs to address this delay
Is this how you market your miracle drug in the midst of a global crisis?
Funny, I haven't heard Brilacidin mentioned once on any of the news coverage over the past few days.
Who's the CEO here? And is this "IPIX" a US-based company?
Remdesivir and Brilacidin
IPIX has reported that a U.S. regional biocontainment laboratory shows the two used together reduces Covid-19 symptoms by nearly 100%.
Is this accurate?
When exactly is the FDA mtg?
Two? Three weeks? Months?
And when is Clay going to show up to flag this one day rally?
DeGrado could talk up Brilacidin
IPIX science advisor has been too quiet. How about talking up Brilacidin a little? Especially now that we could really use something that is 99.85% effective with Remdesivir to be approved.
Todos rocking the contracts
But not much love being shown to shareholders. Price being very carefully controlled for some reason.??
Maybe we'll hear of a deal with Gilead first and then they can fill the room with Cramer.
We must see Leo with Cramer tonight
Enough hiding in the shadows Leo. And bring on the researcher from GMU.
FDA on the clock to approve ASAP
Brilacidin+Remdesivir = Covid-19 crisis done.
Media very quiet
Somebody needs to load up before this gets out.??
Why does IPIX track INO?
Interesting. I don't have a link, but it is very clear that something very strange is going on here.
FDA-laser focus on sanitizers
Wow, good job FDA! 115 hand sanitizers recalled. Bonuses for all staff this year.
Maybe once you guys hit that 1,000th recall you can turn your attention back to approving therapeutic drugs for Covid-19.
Now Fauci says masks AND goggles
...and in a few weeks, he'll be recommending full body spacesuits with helmets. And perhaps a ray gun to stun the alien invaders..
Or the FDA could just approve Brilacidin now and we can just end this already.
Covid patients sent home to die
COVID-19 patients will be ‘sent home to die’ if deemed too sick, Texas county says
https://www.star-telegram.com/news/coronavirus/article244443257.html
All the while Brilacidin sits on a shelf somewhere.
Absolutely heartbreaking.
Watching for one last hard pullback
Big boys watching this, so highly probably retest recent lows around 0.20 before going higher. You thought this was going to be easy?
Keep some cash to be put into action when the time is right.
IPIX STRONG BUY
$3-$6 short term price target
Brilacidin.
IPIX mktcap $108 million
Let me repeat that.
IPIX mktcap $108 MILLION.
About to go KABOOM higher. Way undervalued. :)
Likely from low ball offers. Good for Leo for holding out to get GOLD star valuation here if that is what is going on. And with each successful test, it goes up by a few more dollars. :)
By the way, SRNE walked away from a $7 buyout late last year when it was trading around $2 for the exact same reasons. Big pharma just wants to scoop up gems on the cheap.
Go IPIX!
Another great article on Covid-19
Stop only focussing on the lungs already.
https://www.statnews.com/2020/06/26/from-nose-to-toe-covid19-virus-attacks-like-no-other-respiratory-infection/
Brilacidin could be the answer.
IPIX strong buy. $3-$6 min target by end of July.
PS: The end of the qtr is next Tuesday :)
Someone with YouTube skills
Please make a video of those corporate update slides with some commentary and dump it onto YouTube. Folks, we're not livin' in the 1950s.
Gilead pens $1.5B buyout option deal for Pionyr
Market heating up. No stone left unturned...
INO rec'd Covid-19 funding from the Dept of Defense
https://www.thestreet.com/investing/inovio-shares-up-as-pentagon-funds-vaccine-delivery-device
Interesting to see there are multiple avenues to pursue covid funding in this administration.
INO up on the news with mkt cap of $2.5 billion
SRNE developing covid therapy sitting at $1 billion mkt cap, shares trading at nearly $5 with a $24 target by at least one analyst.
IPIX at less than $200 million mkt cap with ZERO debt, share price at 60 cents. Do the math, IPIX is at minimum worth a $3-$6 stock right now and $12-$20 using rational behind SRNE's $24 target.
And to think that without Covid-19
This company was so close to being buried...and someone thought they would be able to pick up Brilacidin for pennies if/when IPIX went bankrupt.
That won't happen now will it. Bwahaahaahaa!!!!!
100% chance of getting Federal grant
Question is only how much after today's news.
Or whether Pfizer says, "We'll take things from here. Hand over the brilacidin. Thank you. Here's your $billion."
Leo on YouTube?
How 'bout touting your miracle drug a little? Would love to see a presentation and some confidence in Brilacidin.
IPIX mktcap $60M, SRNE $1Billion
Hmmmm...
IPIX vs SRNE
Let the comparisons begin.
Pfizer has $500 million looking
for a home...or perhaps several $Billion if the right candidate presents itself???
Pfizer's $500 million investment fund looking for a home
Go IPIX!
Biotech investment funds
Gonna be doing a lot of explainin' to their investors when IPIX is all over the news soon and they don't have a single share...
Pfizer has some cash $$$ to spend
Small biotech in need of funds. Good guy Pfizer helps to rush miracle drug to market? What kind of return could Pfizer get here?
Covid-19 Therapeutics tracker
242 drugs
154 in human trials
This article shows Brilacidin sitting near the bottom of the list still in a preclinical stage. Why is Brilacidin moving at such a snail's pace falling way behind the rest of the pack?
Is this accurate? What gives? What happened to our miracle drug that is supposedly in an elite top 10 class?
See this link.
https://biorender.com/covid-vaccine-tracker
Newbie shorts dumping on a small biotech that is struggling with little money. I've noticed this happening with many micro biotechs recently. Newbie shorts pile onto any spike and it isn't too difficult if the stock is trading sub $1. As long as the good news keeps rolling from Leo these newbies will get burned soon.
Brilacidin and GI tract issues.
And here is yet another article pointing to coronavirus and the GI tract:
Leading scientists urge UK government to re-examine gut’s role in coronavirus
19-May-2020 By Will Chu
The UK’s most prominent scientists are asking the country’s health secretary Matt Hancock to assess the role of the gut microbiome in coronavirus citing evidence that points to its impact on susceptibility and recovery from the disease.
HTTPS://WWW.NUTRAINGREDIENTS.COM/ARTICLE/2020/05/18/SCIENTISTS-URGE-UK-GOV-TO-LOOK-AT-GUT-S-ROLE-IN-CORONAVIRUS
Yeah, IPIX had something that could help... anyone wanna do a study in England?
CONGRATULATIONS IPIX
Great news. Now the really hard work begins. Time to ramp up staff. Gonna need more than Leo to take this to the finish line and take down Covid-19.
Go Brilacidin. Go IPIX.
Heavy, heavy volume coming today.
COVID-19 Can Infect and Harm Digestive
Organs-posted on WebMD
https://www.webmd.com/lung/news/20200514/covid-19-can-infect-and-harm-digestive-organs
May 14, 2020 (HealthDay News) -- "The new coronavirus isn't just attacking the lungs: New research shows it's causing harm to the gastrointestinal tract, especially in more advanced cases of COVID-19.
A variety of imaging scans performed on hospitalized COVID-19 patients showed bowel abnormalities, according to a study published online May 11 in Radiology. Many of the effects were severe and linked with clots and impairment of blood flow.
"Some findings were typical of bowel ischemia, or dying bowel, and in those who had surgery we saw small vessel clots beside areas of dead bowel," said study lead author Dr. Rajesh Bhayana, who works in the department of radiology at Massachusetts General Hospital in Boston.
"Patients in the ICU can have bowel ischemia for other reasons, but we know COVID-19 can lead to clotting and small vessel injury, so bowel might also be affected by this," Bhayana explained in a journal news release.
One expert unconnected to the new study said the findings aren't surprising.
Our emerging understanding of COVID-19 has found the disease to have multisystem involvement including the nervous, cardiac, vascular [excess clotting] and finally the digestive systems, among others," said Dr. Sherif Andrawes. He directs endoscopy in the division of gastroenterology and hematology at Staten Island University in New York City.
"It seems that this disease is intricate, in the sense that it can involve multiorgan systems, rather than being a disease of the respiratory system solely," Andrawes said.
In fact, a study published online May 13 in the journal Science Immunology has found evidence that SARS-CoV-2, the virus behind COVID-19, can infect the human digestive system.
Researchers led by Siyuan Ding of Washington University School of Medicine in St. Louis, said their findings "highlight the intestine as a potential site of SARS-CoV-2 replication, which may contribute to local and systemic illness and overall disease progression."
That seems to be borne out by the Boston study.
That research included 412 COVID-19 patients who were hospitalized between March 27 and April 10. They averaged 57 years of age, and 134 of them underwent abdominal imaging, including 137 radiographs, 44 ultrasounds, 42 CT scans, and one MRI.
Abnormalities of the bowel wall (intestines and colon) were detected on 31% of CT scans and were more common among patients in intensive care than in other patients, the findings showed.
Bowel abnormalities included thickening and ischemia -- restricted blood flow due to a clot. Surgery was conducted in four patients with bowel abnormalities detected on scans, and it revealed an unusual yellow discoloration of the bowel in three patients, plus bowel infarction ("dead bowel," caused by reduction in blood supply) in two.
The researchers said possible explanations for bowel abnormalities in COVID-19 patients include direct infection by the new coronavirus; clots arising in small vessels that supply the bowel with blood; or what's known as "nonocclusive mesenteric ischemia" -- a condition caused by inadequate blood supply to the intestines.
"Our study is preliminary, and more work is needed to understand the cause of bowel findings in these patients," Bhayana cautioned in a journal news release.
For his part, Andrawes agreed that severe gastrointestinal symptoms are appearing in some COVID-19 patients."
See more at the link above.
Brilacidin could be the solution. Go IPIX.
And thanks for the shares...
Stomach Ills May Signal COVID-19 in Kids
https://www.webmd.com/lung/news/20200512/stomach-ills-may-signal-covid-19-in-kids
TUESDAY, May 12, 2020 (HealthDay News) -- "A cough or other respiratory symptoms aren't the only early signs of COVID-19 in children, according to researchers.
They examined the cases of five children who were admitted to the hospital with digestive tract symptoms and later diagnosed with pneumonia and COVID-19.
Children with sickness and diarrhea who also have a fever or history of exposure to coronavirus should be suspected of having COVID-19, concluded the authors of the study. The findings were published May 12 in the journal Frontiers in Pediatrics.
"These children were seeking medical advice in the emergency department for unrelated problems, for example, one had a kidney stone, another a head trauma. All had pneumonia confirmed by chest CT scan before or soon after admission and then confirmed to have COVID-19," said study author Dr. Wenbin Li, from the Department of Pediatrics at Tongji Hospital in Wuhan, China.
"While their initial symptoms may have been unrelated, or their COVID-19 symptoms were initially mild or relatively hidden before their admission to hospital, importantly, four of the five cases had digestive tract symptoms as the first manifestation of this disease," he said in a journal news release.
Gastrointestinal symptoms initially experienced by some children with COVID-19 suggest that infection could occur through the digestive tract, as the type of receptors in lung cells targeted by the new coronavirus are also found in the intestines, according to Li.
"Most children are only mildly affected by COVID-19 and the few severe cases often have underlying health issues. It is easy to miss its diagnosis in the early stage, when a child has nonrespiratory symptoms or suffers from another illness," he said.
"Based on our experience of dealing with COVID-19, in regions where this virus is epidemic, children suffering from digestive tract symptoms, especially with fever and/or a history of exposure to this disease, should be suspected of being infected with this virus," Li said.
The findings can be used by doctors to quickly diagnose and isolate patients with similar symptoms, which will enable early treatment and reduce transmission of the coronavirus, said Li. However, he cautioned that more study is needed to confirm the findings"
Brilacidin could be a solution. Go IPIX.